YU19299A - Supstituisani tricikli - Google Patents

Supstituisani tricikli

Info

Publication number
YU19299A
YU19299A YU19299A YU19299A YU19299A YU 19299 A YU19299 A YU 19299A YU 19299 A YU19299 A YU 19299A YU 19299 A YU19299 A YU 19299A YU 19299 A YU19299 A YU 19299A
Authority
YU
Yugoslavia
Prior art keywords
substituted tricyclics
tricyclics
substituted
tricycles
class
Prior art date
Application number
YU19299A
Other languages
English (en)
Inventor
Nicholas James Bach
Robert Delane Dillard
Susan Elizabeth Draheim
John Michael Morin
Original Assignee
ELI LILLY AND COMPANY, Proizvodno i trgovinsko preduzeće organizovano po propisima države Indiana, US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELI LILLY AND COMPANY, Proizvodno i trgovinsko preduzeće organizovano po propisima države Indiana, US filed Critical ELI LILLY AND COMPANY, Proizvodno i trgovinsko preduzeće organizovano po propisima države Indiana, US
Publication of YU19299A publication Critical patent/YU19299A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Izložena je klasa novih tricikla zajedno sa upotrebom takvih jedinjenja za inhibiranje sPLA2 posredno oslobodjenog iz masnih kiselina za tretiranje stanja kao što je septični šok.
YU19299A 1996-10-30 1997-10-23 Supstituisani tricikli YU19299A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2984996P 1996-10-30 1996-10-30

Publications (1)

Publication Number Publication Date
YU19299A true YU19299A (sh) 2000-03-21

Family

ID=21851210

Family Applications (1)

Application Number Title Priority Date Filing Date
YU19299A YU19299A (sh) 1996-10-30 1997-10-23 Supstituisani tricikli

Country Status (26)

Country Link
EP (1) EP0839806B1 (sh)
JP (1) JP2001503055A (sh)
KR (1) KR20000049210A (sh)
CN (1) CN1233176A (sh)
AR (1) AR010050A1 (sh)
AT (1) ATE244703T1 (sh)
AU (1) AU734096B2 (sh)
BR (1) BR9713261A (sh)
CA (1) CA2269203A1 (sh)
CO (1) CO4920250A1 (sh)
CZ (1) CZ136899A3 (sh)
DE (1) DE69723393T2 (sh)
DK (1) DK0839806T3 (sh)
EA (1) EA003992B1 (sh)
ES (1) ES2202560T3 (sh)
ID (1) ID18685A (sh)
IL (1) IL129481A0 (sh)
NO (1) NO314899B1 (sh)
NZ (1) NZ335246A (sh)
PE (1) PE10999A1 (sh)
PL (1) PL332896A1 (sh)
PT (1) PT839806E (sh)
TR (1) TR199900956T2 (sh)
TW (1) TW513428B (sh)
WO (1) WO1998018464A1 (sh)
YU (1) YU19299A (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009978A1 (en) * 1997-08-28 1999-03-04 Eli Lilly And Company Method for treatment of non-rheumatoid athritis
CA2326522A1 (en) 1998-03-31 1999-10-14 Shionogi & Co., Ltd. Pyrrolo[1,2-a]pyrazine spla2 inhibitor
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
ID23219A (id) * 1998-04-17 2000-03-30 Lilly Co Eli Trisiklik tersubstitusi
BR9910095A (pt) 1998-05-01 2000-12-26 Lilly Co Eli Compostos inibidores de spla2 para tratamento de doença
CA2332528A1 (en) 1998-05-21 1999-11-25 Shionogi & Co., Ltd. Pyrrolo[1,2-b]pyridazine spla2 inhibitory
WO2000021563A1 (fr) * 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Moyens de traitement et de prevention contre les troubles ischemiques dus a la repercussion
AU1928800A (en) * 1998-12-22 2000-07-12 Eli Lilly And Company Substituted tricyclics
JP4636521B2 (ja) 1999-07-19 2011-02-23 塩野義製薬株式会社 ｓＰＬＡ２阻害作用を有する三環系化合物
JP4636522B2 (ja) 1999-08-02 2011-02-23 塩野義製薬株式会社 ｓＰＬＡ２阻害作用を有する三環式化合物
US6787545B1 (en) 1999-08-23 2004-09-07 Shiongi & Co., Ltd. Pyrrolotriazine derivatives having spla2-inhibitory activities
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
WO2001036420A1 (fr) 1999-11-15 2001-05-25 Shionogi & Co., Ltd. Derives d'aza-indolizine tricyclique ayant un effet inhibiteur sur spla¿2?
JP2003519198A (ja) * 2000-01-06 2003-06-17 イーライ・リリー・アンド・カンパニー 炎症性疾患および呼吸器疾患の処置のための併用療法
AU2001267823A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
WO2002000256A1 (en) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
AU2002239263A1 (en) * 2000-12-18 2002-07-01 Eli Lilly And Company Tetracyclic carbazole derivates and their use as spla2 inhibitors
TWI314457B (sh) * 2001-03-19 2009-09-11 Shionogi & Co
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
ES2378177T3 (es) 2004-10-29 2012-04-09 Zeria Pharmaceutical Co., Ltd. Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable
US10632102B2 (en) 2015-06-15 2020-04-28 Raziel Therapeutics Ltd Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
CN112409493B (zh) * 2020-08-12 2022-09-30 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479391A (en) * 1966-10-03 1969-11-18 Squibb & Sons Inc Delta**3,14-17alpha-hydroxy-norprogesterone and esters
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors

Also Published As

Publication number Publication date
IL129481A0 (en) 2000-02-29
CA2269203A1 (en) 1998-05-07
EA003992B1 (ru) 2003-12-25
EP0839806A1 (en) 1998-05-06
CZ136899A3 (cs) 1999-09-15
TW513428B (en) 2002-12-11
JP2001503055A (ja) 2001-03-06
ID18685A (id) 1998-04-30
WO1998018464A1 (en) 1998-05-07
NO314899B1 (no) 2003-06-10
AR010050A1 (es) 2000-05-17
DK0839806T3 (da) 2003-10-27
NZ335246A (en) 2001-09-28
NO991831L (no) 1999-06-21
BR9713261A (pt) 2000-03-28
AU5149498A (en) 1998-05-22
PE10999A1 (es) 1999-02-10
PT839806E (pt) 2003-11-28
EP0839806B1 (en) 2003-07-09
CN1233176A (zh) 1999-10-27
CO4920250A1 (es) 2000-05-29
DE69723393D1 (de) 2003-08-14
EA199900305A1 (ru) 1999-12-29
KR20000049210A (ko) 2000-07-25
TR199900956T2 (xx) 1999-07-21
AU734096B2 (en) 2001-06-07
NO991831D0 (no) 1999-04-16
ES2202560T3 (es) 2004-04-01
ATE244703T1 (de) 2003-07-15
DE69723393T2 (de) 2004-06-09
PL332896A1 (en) 1999-10-25

Similar Documents

Publication Publication Date Title
YU19299A (sh) Supstituisani tricikli
DK0675110T3 (da) 1H-indol-3-glyoxylamid-sPLA2-inhibitorer
ATE246501T1 (de) Pyrrole als spla2 inhibitoren
ATE248153T1 (de) Neue benzoxazole
FI962246A0 (fi) Apoptoosia inhiboivat koostumukset, koostumusten puhdistusmenetelmät ja niiden käyttö
EA199900303A2 (ru) Замещенные трициклические соединения
EA199900304A2 (ru) Замещенные трициклические соединения
ES2160897T3 (es) Pirazoles como inhibidores de la secretora fosfolipasa a2 humana no pancreatica.
ATE326963T1 (de) Indolverbindungen als spla2 inhibitoren
ATE234850T1 (de) Phenylglyoxamide als spla2-inhibitoren
DE69614232D1 (de) Naphthyl-Acetamide als sPLA2-Inhibitoren
FI950842A0 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
ES2181052T3 (es) Fenilacetamidas como inhibidores de la spla2.
DE69910432D1 (de) Substituierte pyrroloindole
NO20006478L (no) Fremgangsmåter for inhibering av korrosjon ved anvendelse av isomerer av klor-metylbenzotriazol
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
ES2090530T3 (es) Produccion de peces mejorada.
ATE350367T1 (de) Spla2 inhibitoren
HN1997000071A (es) Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido
DE60032254D1 (de) Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren
SU1602053A1 (ru) Штамм бактерий pseudomonas acidovorans, используемый для очистки сточных вод от ароматических ди- и трикарбоновых кислот
GR960100054A (el) Βιολοντσελλο μελετης.